Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Vaximm AG
DescriptionImmunotherapy that targets a tumor-antigen that is associated with colorectal cancer cells and other solid tumors
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationColorectal cancer
Indication DetailsTreat advanced colorectal cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today